Recommended starting dose: Discontinue other basal insulin and/or GLP-1 agonist before initiating Soliqua Patients naive to basal insulin or a GLP-1 agonist, currently on a GLP-1 agonist or less than 30 units of basal insulin daily: starting dose is 15 units once daily Patients currently on 30 to 60 units of basal insulin daily, with or without a GLP-1 agonist: starting dose is 30 units once daily Maintenance: titrate dose up or down by 2 - 4 units every week based on blood sugar goals Missed doses: resume dosing at the next scheduled dose
64 Mosenzon O, Wiviott SD, Cahn A, Rozenberg A, Yanuv I, Goodrich EL, et al
Kisspeptin dosing is weight-based (nmol/kg), not a flat dose, and is not standardized outside clinical research
The brand is owned by SIF Medicos
Researchers who buy AOD-9604 through institutional channels receive Canadian tax documentation and CAD-denominated invoicing as standard issue
For injection administration guidance, visit our videos page